Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

Bibliographic Details
Main Authors:	Gerardo Aguilar, Rafael Ferriols, Angels Lozano, Carlos Ezquer, José A. Carbonell, Ana Jurado, Juan Carrizo, Ferran Serralta, Jaume Puig, David Navarro, Manuel Alos, F. Javier Belda
Format:	Article
Language:	English
Published:	BMC 2017-01-01
Series:	Critical Care
Subjects:	Echinocandins Continuous renal replacement therapy Invasive candidiasis
Online Access:	http://link.springer.com/article/10.1186/s13054-016-1594-9

Similar Items

Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
by: Gerardo Aguilar, et al.
Published: (2019-04-01)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022-10-01)

Plasma concentrations of caspofungin in a critically ill patient with morbid obesity
by: Rafael Ferriols-Lisart, et al.
Published: (2017-08-01)

Results of treatment for candidemia in patients with blood system tumors
by: G A Kliasova, et al.
Published: (2013-11-01)

Modern approaches to the therapy of invasive mycoses in cancer patients
by: Aleksey O. Prikhodchenko, et al.
Published: (2021-08-01)

Susceptibility testing of Candida glabrata clinical strains to echinocandins using SensititreTM YeastOneTM system
by: Veselov A.V., et al.
Published: (2018-02-01)

INVASIVE MYCOSES IN INTENSIVE CARE UNITS
by: Yakubtsevich R. E.
Published: (2020-03-01)

Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features
by: Noelia Pérez-González, et al.
Published: (2023-04-01)

Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
by: J. Myles Keck, et al.
Published: (2023-01-01)

Criteria for the administration of systemic antimicotic therapy in surgical intensive care units (literature review)
by: B. Z. Belotserkovskiy, et al.
Published: (2019-11-01)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
by: Ensieh Lotfali, et al.
Published: (2022-06-01)

Candida glabrata Resistance to Echinocandins Associated with FKS Genes Mutations: How Urgent is the Problem?
by: Veselov A.V.
Published: (2016-05-01)

Genomic and Molecular Identification of Genes Contributing to the Caspofungin Paradoxical Effect in Aspergillus fumigatus
by: Shu Zhao, et al.
Published: (2022-10-01)

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01)

Postantifungal Effect of Antifungal Drugs against <i>Candida</i>: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?
by: Nerea Jauregizar, et al.
Published: (2022-07-01)

Update 2016–2018 of the Nationwide Danish Fungaemia Surveillance Study: Epidemiologic Changes in a 15-Year Perspective
by: Malene Risum, et al.
Published: (2021-06-01)

Treatment of Invasive Candidiasis: A Narrative Review
by: Ronen Ben-Ami
Published: (2018-08-01)

Review of the guidelines for the treatment and prevention of invasive candidiasis in newborns and children
by: Veselov A.V.
Published: (2017-05-01)

Effect of Phoxilium on prognostic predictors in patients undergoing continuous venovenous hemodiafiltration
by: Da Woon Kim, et al.
Published: (2021-09-01)

Reply to the reply to Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future …
by: Guillaume Desoubeaux, et al.
Published: (2020-06-01)

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
by: Egerer Gerlinde, et al.
Published: (2012-04-01)

Successful management of recalcitrant fungal keratitis with topical caspofungin
by: Goel, Siddhi, et al.
Published: (2022-07-01)

Candida spp. peritonitis (clinical cases, register analysis and literature review)
by: Kozlova O.P., et al.
Published: (2023-09-01)

Caspofungin Inhibits Mixed Biofilms of Candida albicans and Methicillin-Resistant Staphylococcus aureus and Displays Effectiveness in Coinfected Galleria mellonella Larvae
by: Gaby Scheunemann, et al.
Published: (2021-10-01)

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
by: Prépost E, et al.
Published: (2019-07-01)

Prognostic factors of Candida spp. bloodstream infection in adults: A nine-year retrospective cohort study across tertiary hospitals in Brazil and Spain
by: Caroline Agnelli, et al.
Published: (2022-02-01)

The effectiveness of continuous venovenous hemodiafiltration in phenobarbital intoxication
by: Yasemin Çoban, et al.
Published: (2018-01-01)

Caspofungin Induced Cell Wall Changes of Candida Species Influences Macrophage Interactions
by: Louise A. Walker, et al.
Published: (2020-05-01)

Breakthrough invasive candidiasis in pediatric patient with Ewing’s sarcoma: dinical case report and literature review
by: Yu. V. Dinikina, et al.
Published: (2019-12-01)

New Horizons in Antifungal Therapy
by: Kaila M. Pianalto, et al.
Published: (2016-10-01)

Identification of Genes in Candida glabrata Conferring Altered Responses to Caspofungin, a Cell Wall Synthesis Inhibitor
by: Anne G. Rosenwald, et al.
Published: (2016-09-01)

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against <i>Candida auris</i>
by: Unai Caballero, et al.
Published: (2021-08-01)

The Efficacy of Continuous Venovenous Hemodiafiltration with Cytokine Filter on Sepsis
by: Mehtap Yıldırım, et al.
Published: (2020-01-01)

Continuous Venovenous Hemodiafiltration in Three Newborn Patients with Hyperammonemia
by: Hacer Yapicioglu Yildizdas, et al.
Published: (2015-03-01)

Mortality predictors in acute kidney injury patients who underwent continuous venovenous hemodiafiltration: A retrospective, single-center study
by: Alper Alp, et al.
Published: (2021-05-01)

<i>Candida albicans</i> Genes Modulating Echinocandin Susceptibility of Caspofungin-Adapted Mutants Are Constitutively Expressed in Clinical Isolates with Intermediate or Full Resistance to Echinocandins
by: Anshuman Yadav, et al.
Published: (2024-03-01)

<i>Candida albicans</i> Strains Adapted to Caspofungin Due to Aneuploidy Become Highly Tolerant under Continued Drug Pressure
by: Farha Husain, et al.
Published: (2022-12-01)

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four <i>Candida auris</i> Clades in RPMI-1640 in the Absence and Presence of Human Serum
by: Renátó Kovács, et al.
Published: (2021-04-01)

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against <i>Candida</i> Species
by: Zoltán Tóth, et al.
Published: (2020-08-01)

Continuous venovenous hemodiafiltration versus standard medical therapy for the prevention of rhabdomyolysis-induced acute kidney injury: a retrospective cohort study
by: Yan Meng, et al.
Published: (2023-07-01)